- Home
- TCRX vs FONR Comparison
TCRX vs FONR Comparison
Compare TCRX & FONR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCRX
- FONR
- Stock Information
- Founded
- TCRX 2018
- FONR 1978
- Country
- TCRX United States
- FONR United States
- Employees
- TCRX N/A
- FONR N/A
- Industry
- TCRX Biotechnology: Pharmaceutical Preparations
- FONR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- TCRX Health Care
- FONR Health Care
- Exchange
- TCRX Nasdaq
- FONR Nasdaq
- Market Cap
- TCRX 98.5M
- FONR 94.1M
- IPO Year
- TCRX 2021
- FONR 1987
- Fundamental
- Price
- TCRX $1.38
- FONR $14.02
- Analyst Decision
- TCRX Strong Buy
- FONR
- Analyst Count
- TCRX 6
- FONR 0
- Target Price
- TCRX $9.83
- FONR N/A
- AVG Volume (30 Days)
- TCRX 442.7K
- FONR 10.5K
- Earning Date
- TCRX 03-05-2025
- FONR 05-14-2025
- Dividend Yield
- TCRX N/A
- FONR N/A
- EPS Growth
- TCRX N/A
- FONR N/A
- EPS
- TCRX N/A
- FONR 1.17
- Revenue
- TCRX $2,816,000.00
- FONR $101,570,089.00
- Revenue This Year
- TCRX $32.21
- FONR N/A
- Revenue Next Year
- TCRX $118.35
- FONR N/A
- P/E Ratio
- TCRX N/A
- FONR $11.84
- Revenue Growth
- TCRX N/A
- FONR N/A
- 52 Week Low
- TCRX $1.28
- FONR $13.27
- 52 Week High
- TCRX $9.69
- FONR $21.25
- Technical
- Relative Strength Index (RSI)
- TCRX 31.10
- FONR 46.53
- Support Level
- TCRX $1.44
- FONR $13.70
- Resistance Level
- TCRX $1.76
- FONR $14.14
- Average True Range (ATR)
- TCRX 0.17
- FONR 0.31
- MACD
- TCRX -0.01
- FONR 0.08
- Stochastic Oscillator
- TCRX 16.39
- FONR 71.22
About TCRX TScan Therapeutics Inc.
TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.
About FONR Fonar Corporation
Fonar Corp is a United States-based company which is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance imaging (MRI) scanners, which utilize MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions, and injuries. The company operates through two segments namely Manufacturing and servicing of medical equipment; and the Management of diagnostic imaging centers, which generates a vast majority of the revenue.